Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
2.080
-0.050 (-2.35%)
At close: Oct 7, 2025
-2.35%
Market Cap302.13M
Revenue (ttm)361.97M
Net Income (ttm)21.53M
Shares Out141.84M
EPS (ttm)0.15
PE Ratio14.04
Forward PEn/a
Dividend0.11 (5.24%)
Ex-Dividend DateJun 25, 2025
Volume5,200
Average Volume18,640
Open2.090
Previous Close2.130
Day's Range2.080 - 2.090
52-Week Range1.980 - 2.550
Beta-0.00
RSI55.99
Earnings DateNov 19, 2025

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 1,381
Stock Exchange Bursa Malaysia
Ticker Symbol YSPSAH
Full Company Profile

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.

Financial Statements

News

There is no news available yet.